Text Size

Ocular Treatments Targeting Separate Prostaglandin Receptors in Mice Exhibit Alterations in Intraocular Pressure and Optic Nerve Lipidome

Arcuri J, Elbaz A, Sharif NA, Bhattacharya SK


  • 2023
  • J Ocul Pharmacol Ther
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Preclinical development

  • Affiliations

    Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine at University of Miami, Miami, Florida, USA; Miami Integrative Metabolomics Research Center, Miami, Florida, USA; Molecular Cellular Pharmacology Graduate Program, University of Miami, Miami, Florida, USA; Eye-APC Duke-National University of Singapore Medical School, Singapore; Singapore Eye Research Institute, Singapore; Department of Pharmacology and Neuroscience, University of North Texas Health Sciences Center, Fort Worth, Texas, USA; Department of Pharmacy Sciences, Creighton University, Omaha, Nebraska, USA; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas, USA; Imperial College of Science and Technology, St. Mary's Campus, London, United Kingdom; Institute of Ophthalmology, University College London, London, United Kingdom; Ophthalmology Innovation Center and Product Development Division, Santen Inc., Emeryville, California, USA

Related Publications

Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Taniguchi T.; Sharif N.A.; Ota T.; Farjo R.A.; Rausch R.


24-Hour Evaluation of the Effectiveness and Tolerability of Preservative-Free Tafluprost-Timolol Fixed Combination in Open-Angle Glaucoma or Ocular Hypertensive Patients Previously Treated with Preserved Latanoprost

Oddone F, Tanga L, Giammaria S, Sabbatini L, Strianese A, Ferrazza M, Rossetti LM


MicroRNA profile of extracellular vesicles released by Müller glial cells

Lamb W D.B.; Eastlake K.; Luis J.; Sharif N.A. ; Khaw P. T.; Limb G. A.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022